3/14/2008

The FDA has granted Abbott Laboratories approval to market its FreeStyle Navigator system, designed to continuously monitor the blood-sugar levels of diabetics. The device, which was cleared by European regulators last June, will be available in the second quarter of 2008 by prescription.

Related Summaries